Myxoid and Hyalinized Fibroplasia of the Aortic Valve
Myxoid and hyalinized fibroplasia (also termed myxomatous degeneration) of the aortic valve is primarily caused by a degenerative connective tissue disorder characterized by disruption of the valve's fibrosa layer with accumulation of acid mucopolysaccharides, often associated with long-standing systemic hypertension, aging, and possibly genetic predisposition.
Primary Pathophysiologic Mechanism
The fundamental process involves non-inflammatory degeneration where the structural integrity of the aortic valve leaflets breaks down 1, 2. Specifically:
- The fibrosa layer (the valve's main structural component) becomes disrupted and replaced by acid mucopolysaccharides
- This leads to expansion of the spongiosa layer (>50% expansion defines severe disease)
- Cystic changes develop within the valve tissue
- The result is weakened, redundant valve leaflets that fail to coapt properly, causing regurgitation
Major Contributing Factors
Age-Related Degeneration
Myxoid degeneration predominantly affects older adults, with an average age of 63 years in surgical series 2. This represents the most common cause of isolated aortic insufficiency in contemporary urban populations, accounting for approximately 36-42% of cases requiring valve replacement 1, 2.
Systemic Hypertension
Long-standing hypertension is present in 77% of patients with myxoid degeneration 2. The chronic hemodynamic stress appears to accelerate the degenerative process, though the exact mechanism remains incompletely understood. This is distinct from acute hypertensive injury and represents cumulative damage over years.
Genetic and Connective Tissue Factors
While most cases are sporadic, there is evidence of familial clustering:
- X-linked myxomatous valvular dystrophy has been mapped to Xq28 3
- These familial forms affect both mitral and aortic valves
- There may be overlap with generalized connective tissue disorders, even in non-Marfan patients 1
Association with Aortic Root Disease
In patients with both aortic insufficiency and aortic root dilatation/aneurysm:
- 42% have isolated myxoid degeneration of the valve
- 25% have both valve myxoid degeneration AND cystic medial degeneration of the aorta
- This suggests a spectrum of connective tissue disease affecting both structures 1
Important Clinical Distinctions
This entity must be distinguished from:
Calcific degeneration - The most common cause of aortic stenosis, characterized by lipid accumulation, inflammation, fibrosis, and calcification 4, 5. This is a different pathologic process.
Rheumatic disease - Causes commissural fusion with scarring and calcification, typically affecting multiple valves 4, 6
Infective endocarditis - Acute inflammatory destruction rather than chronic degeneration 7
Bicuspid valve disease - Congenital abnormality that may have superimposed degenerative changes 7
Clinical Presentation Pattern
Patients typically present with:
- Isolated aortic regurgitation (not stenosis)
- Progressive dyspnea and heart failure symptoms 8, 9
- Predominantly male (85%) 2
- Often have concurrent coronary artery disease (46%) 2
Critical pitfall: The valve annulus is typically NOT dilated in pure myxoid degeneration 2. If significant annular dilatation is present, consider concurrent aortic root pathology or a different etiology.
Pathologic Confirmation
Definitive diagnosis requires histopathologic examination showing:
- Significant disruption of the fibrosa
- Replacement by acid mucopolysaccharides (positive on special stains)
- Cystic changes
- Absence of significant calcification, inflammation, or rheumatic changes 1, 2, 8, 9
The hyalinized component represents areas of collagen deposition and fibrosis that occur as part of the chronic degenerative process, often intermixed with the myxoid areas.